390 related articles for article (PubMed ID: 9751114)
1. Mutation of Thr115 in MyoD positively regulates function in murine fibroblasts and human rhabdomyosarcoma cells.
Liu LN; Dias P; Houghton PJ
Cell Growth Differ; 1998 Sep; 9(9):699-711. PubMed ID: 9751114
[TBL] [Abstract][Full Text] [Related]
2. p21WAF1 expression induced by MEK/ERK pathway activation or inhibition correlates with growth arrest, myogenic differentiation and onco-phenotype reversal in rhabdomyosarcoma cells.
Ciccarelli C; Marampon F; Scoglio A; Mauro A; Giacinti C; De Cesaris P; Zani BM
Mol Cancer; 2005 Dec; 4():41. PubMed ID: 16351709
[TBL] [Abstract][Full Text] [Related]
3. p53/p21(CIP1) cooperate in enforcing rapamycin-induced G(1) arrest and determine the cellular response to rapamycin.
Huang S; Liu LN; Hosoi H; Dilling MB; Shikata T; Houghton PJ
Cancer Res; 2001 Apr; 61(8):3373-81. PubMed ID: 11309295
[TBL] [Abstract][Full Text] [Related]
4. Bone morphogenetic protein-2 inhibits terminal differentiation of myogenic cells by suppressing the transcriptional activity of MyoD and myogenin.
Katagiri T; Akiyama S; Namiki M; Komaki M; Yamaguchi A; Rosen V; Wozney JM; Fujisawa-Sehara A; Suda T
Exp Cell Res; 1997 Feb; 230(2):342-51. PubMed ID: 9024793
[TBL] [Abstract][Full Text] [Related]
5. Muscle regulatory factor MRF4 activates differentiation in rhabdomyosarcoma RD cells through a positive-acting C-terminal protein domain.
Sirri V; Leibovitch MP; Leibovitch SA
Oncogene; 2003 Aug; 22(36):5658-66. PubMed ID: 12944914
[TBL] [Abstract][Full Text] [Related]
6. Evidence that E-box promoter elements and MyoD transcription factors play a role in the induction of cathepsin B gene expression during human myoblast differentiation.
Jane DT; Morvay LC; Koblinski J; Yan S; Saad FA; Sloane BF; Dufresne MJ
Biol Chem; 2002 Dec; 383(12):1833-44. PubMed ID: 12553720
[TBL] [Abstract][Full Text] [Related]
7. Cellular cardiomyoplasty of cardiac fibroblasts by adenoviral delivery of MyoD ex vivo: an unlimited source of cells for myocardial repair.
Etzion S; Barbash IM; Feinberg MS; Zarin P; Miller L; Guetta E; Holbova R; Kloner RA; Kedes LH; Leor J
Circulation; 2002 Sep; 106(12 Suppl 1):I125-30. PubMed ID: 12354721
[TBL] [Abstract][Full Text] [Related]
8. Elevated cyclins and cyclin-dependent kinase activity in the rhabdomyosarcoma cell line RD.
Knudsen ES; Pazzagli C; Born TL; Bertolaet BL; Knudsen KE; Arden KC; Henry RR; Feramisco JR
Cancer Res; 1998 May; 58(9):2042-9. PubMed ID: 9581851
[TBL] [Abstract][Full Text] [Related]
9. Effect of phase limited inhibition of MyoD expression on the terminal differentiation of bovine myoblasts: no alteration of Myf5 or myogenin expression.
Muroya S; Nakajima I; Oe M; Chikuni K
Dev Growth Differ; 2005 Sep; 47(7):483-92. PubMed ID: 16179075
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia affects positively the proliferation of bovine satellite cells and their myogenic differentiation through up-regulation of MyoD.
Kook SH; Son YO; Lee KY; Lee HJ; Chung WT; Choi KC; Lee JC
Cell Biol Int; 2008 Aug; 32(8):871-8. PubMed ID: 18468460
[TBL] [Abstract][Full Text] [Related]
11. MyoD induces apoptosis in the absence of RB function through a p21(WAF1)-dependent re-localization of cyclin/cdk complexes to the nucleus.
Peschiaroli A; Figliola R; Coltella L; Strom A; Valentini A; D'Agnano I; Maione R
Oncogene; 2002 Nov; 21(53):8114-27. PubMed ID: 12444547
[TBL] [Abstract][Full Text] [Related]
12. SV40 T antigen inhibits expression of MyoD and myogenin, up-regulates Myf-5, but does not affect early expression of desmin or alpha 7 integrin during muscle development.
Haider SR; Wang W; Kaufman SJ
Exp Cell Res; 1994 Feb; 210(2):278-86. PubMed ID: 7507852
[TBL] [Abstract][Full Text] [Related]
13. Dual promoter structure of ZFP106: regulation by myogenin and nuclear respiratory factor-1.
Grasberger H; Ye H; Mashima H; Bell GI
Gene; 2005 Jan; 344():143-59. PubMed ID: 15656981
[TBL] [Abstract][Full Text] [Related]
14. MyoD induces the expression of p57Kip2 in cells lacking p21Cip1/Waf1: overlapping and distinct functions of the two cdk inhibitors.
Figliola R; Maione R
J Cell Physiol; 2004 Sep; 200(3):468-75. PubMed ID: 15254975
[TBL] [Abstract][Full Text] [Related]
15. Hypermethylated myoblasts specifically deficient in MyoD autoactivation as a consequence of instability of MyoD.
Horwitz M
Exp Cell Res; 1996 Jul; 226(1):170-82. PubMed ID: 8660953
[TBL] [Abstract][Full Text] [Related]
16. MyoD(-/-) satellite cells in single-fiber culture are differentiation defective and MRF4 deficient.
Cornelison DD; Olwin BB; Rudnicki MA; Wold BJ
Dev Biol; 2000 Aug; 224(2):122-37. PubMed ID: 10926754
[TBL] [Abstract][Full Text] [Related]
17. Transactivation of cardiac MLC-2 promoter by MyoD in 10T1/2 fibroblast cells is independent of E-box requirement but depends upon new proteins that recognize MEF-2 site.
Goswami SK; Siddiqui MA
Cell Mol Biol Res; 1995; 41(3):199-205. PubMed ID: 8589760
[TBL] [Abstract][Full Text] [Related]
18. Muscle-specific transcription factors in fibroblasts expressing the alpha-striated tropomyosin 3' untranslated region.
L'ecuyer TJ; Schutte BC; Mendel KA; Morris E; Fulton AB
Mol Genet Metab; 1999 Jul; 67(3):213-26. PubMed ID: 10381329
[TBL] [Abstract][Full Text] [Related]
19. The involvement of proteasome in myogenic differentiation of murine myocytes and human rhabdomyosarcoma cells.
Mugita N; Honda Y; Nakamura H; Fujiwara T; Tanaka K; Omura S; Shimbara N; Ogawa M; Saya H; Nakao M
Int J Mol Med; 1999 Feb; 3(2):127-37. PubMed ID: 9917519
[TBL] [Abstract][Full Text] [Related]
20. MyoD cannot compensate for the absence of myogenin during skeletal muscle differentiation in murine embryonic stem cells.
Myer A; Olson EN; Klein WH
Dev Biol; 2001 Jan; 229(2):340-50. PubMed ID: 11203698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
